APA (7th ed.) Citation

AS, A., N, A., H, A. A., IH, A., A, A., AW, L., . . . M, M. (2026). Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus. Infectious diseases and therapy. https://doi.org/10.1007/s40121-026-01386-5

Chicago Style (17th ed.) Citation

AS, Alharbi, et al. "Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus." Infectious Diseases and Therapy 2026. https://doi.org/10.1007/s40121-026-01386-5.

MLA (9th ed.) Citation

AS, Alharbi, et al. "Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus." Infectious Diseases and Therapy, 2026, https://doi.org/10.1007/s40121-026-01386-5.